These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 24786362)
1. Subcellular localization and transport kinetics of ruthenium organometallic anticancer compounds in living cells: a dose-dependent role for amino acid and iron transporters. Klajner M; Licona C; Fetzer L; Hebraud P; Mellitzer G; Pfeffer M; Harlepp S; Gaiddon C Inorg Chem; 2014 May; 53(10):5150-8. PubMed ID: 24786362 [TBL] [Abstract][Full Text] [Related]
3. Synthesis, characterization, and anticancer activity of ruthenium(II)-β-carboline complex. Chen Y; Qin MY; Wu JH; Wang L; Chao H; Ji LN; Xu AL Eur J Med Chem; 2013; 70():120-9. PubMed ID: 24141202 [TBL] [Abstract][Full Text] [Related]
4. Synthesis of iridium and ruthenium complexes with (N,N), (N,O) and (O,O) coordinating bidentate ligands as potential anti-cancer agents. Lucas SJ; Lord RM; Wilson RL; Phillips RM; Sridharan V; McGowan PC Dalton Trans; 2012 Dec; 41(45):13800-2. PubMed ID: 23015068 [TBL] [Abstract][Full Text] [Related]
5. Complexation with organometallic ruthenium pharmacophores enhances the ability of 4-anilinoquinazolines inducing apoptosis. Zheng W; Luo Q; Lin Y; Zhao Y; Wang X; Du Z; Hao X; Yu Y; Lü S; Ji L; Li X; Yang L; Wang F Chem Commun (Camb); 2013 Nov; 49(87):10224-6. PubMed ID: 23856988 [TBL] [Abstract][Full Text] [Related]
6. A novel ruthenium(II) arene based intercalator with potent anticancer activity. Ruiz J; Vicente C; de Haro C; Bautista D Dalton Trans; 2009 Jul; (26):5071-3. PubMed ID: 19562164 [TBL] [Abstract][Full Text] [Related]
7. Novel ruthenium complexes ligated with 4-anilinoquinazoline derivatives: synthesis, characterisation and preliminary evaluation of biological activity. Ji L; Zheng W; Lin Y; Wang X; Lü S; Hao X; Luo Q; Li X; Yang L; Wang F Eur J Med Chem; 2014 Apr; 77():110-20. PubMed ID: 24631730 [TBL] [Abstract][Full Text] [Related]
8. Design of Ru-arene Complexes for Antitumor Drugs. Su W; Li Y; Li P Mini Rev Med Chem; 2018; 18(2):184-193. PubMed ID: 28494728 [TBL] [Abstract][Full Text] [Related]
9. Cyclopentadienyl-ruthenium(II) and iron(II) organometallic compounds with carbohydrate derivative ligands as good colorectal anticancer agents. Florindo PR; Pereira DM; Borralho PM; Rodrigues CM; Piedade MF; Fernandes AC J Med Chem; 2015 May; 58(10):4339-47. PubMed ID: 25923600 [TBL] [Abstract][Full Text] [Related]
10. Discovery and investigation of anticancer ruthenium-arene Schiff-base complexes via water-promoted combinatorial three-component assembly. Chow MJ; Licona C; Yuan Qiang Wong D; Pastorin G; Gaiddon C; Ang WH J Med Chem; 2014 Jul; 57(14):6043-59. PubMed ID: 25023617 [TBL] [Abstract][Full Text] [Related]
11. Synthesis, interaction with DNA, cytotoxicity, cell cycle arrest and apoptotic inducing properties of ruthenium(II) molecular "light switch" complexes. Shobha Devi C; Anil Kumar D; Singh SS; Gabra N; Deepika N; Kumar YP; Satyanarayana S Eur J Med Chem; 2013 Jun; 64():410-21. PubMed ID: 23665797 [TBL] [Abstract][Full Text] [Related]